Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PDUFA Negotiations: Early Communications, Breakthrough Still On Docket

18 Feb 2016

• By Derrick Gingery

Related Content

PDUFA VI: Breakthrough Issues Among FDA Priorities

07 Dec 2015

Breakthrough Requests: FDA Adds Quick Screen To Pare Workload

13 Nov 2015

Califf Supports Combo Products Pathway At Confirmation Hearing

17 Nov 2015

PDUFA VI: Innovative Trial Design Talks Can’t Have Formal Meeting Goals, FDA Says

30 Nov 2015

Investors Like “Breakthrough” Therapies, But Real Test Still To Come

22 Dec 2014

Additional Topics

United States Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.